Skip to content

Advertisement

BMC Cancer

What do you think about BMC? Take part in

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Hedgehog inhibitor sonidegib potentiates 177Lu-octreotate therapy of GOT1 human small intestine neuroendocrine tumors in nude mice

BMC Cancer201717:528

https://doi.org/10.1186/s12885-017-3524-x

Received: 11 October 2016

Accepted: 1 August 2017

Published: 8 August 2017

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
11 Oct 2016 Submitted Original manuscript
26 Jan 2017 Reviewed Reviewer Report - Yongsong Guan
13 Feb 2017 Reviewed Reviewer Report - Ana-Maria Florea
5 Jun 2017 Author responded Author comments - Johan Spetz
Resubmission - Version 2
5 Jun 2017 Submitted Manuscript version 2
13 Jun 2017 Reviewed Reviewer Report - Ana-Maria Florea
5 Jul 2017 Author responded Author comments - Johan Spetz
Resubmission - Version 3
5 Jul 2017 Submitted Manuscript version 3
10 Jul 2017 Reviewed Reviewer Report - Ana-Maria Florea
21 Jul 2017 Author responded Author comments - Johan Spetz
Resubmission - Version 4
21 Jul 2017 Submitted Manuscript version 4
Publishing
1 Aug 2017 Editorially accepted
8 Aug 2017 Article published 10.1186/s12885-017-3524-x

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Department of Radiation Physics, Institute of Clinical Sciences, Sahlgrenska Cancer Center, Sahlgrenska Academy, University of Gothenburg, Sahlgrenska University Hospital
(2)
Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Cancer Center, Sahlgrenska Academy, University of Gothenburg, Sahlgrenska University Hospital
(3)
Department of Pathology, Institute of Biomedicine, Sahlgrenska Cancer Center, Sahlgrenska Academy, University of Gothenburg, Sahlgrenska University Hospital

Advertisement